On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Tim A. Kanters

ResearcherPublications, citations & collaboration network

Tim A. Kanters is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Tim A. Kanters have?

ScholarIQindexed works

Tim A. Kanters has 63 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Tim A. Kanters have?

ScholarIQcitation count

Tim A. Kanters has 1,078 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Tim A. Kanters?

ScholarIQh-index

Tim A. Kanters has an h-index of 21 in OpenAlex.

What is the i10-index of Tim A. Kanters?

ScholarIQi10-index

Tim A. Kanters has an i10-index of 29 in OpenAlex.

What is the ORCID of Tim A. Kanters?

ScholarIQorcid

The ORCID for Tim A. Kanters is on the source record.

What is the OpenAlex record for Tim A. Kanters?

ScholarIQopenalex

The OpenAlex for Tim A. Kanters is on the source record.

What are the most-cited papers on Tim A. Kanters?

ScholarIQmost cited works
Update of the Dutch manual for costing studies in health care
Tim A. Kanters, Clazien Bouwmans, Naomi van der Linden, Siok Swan Tan, Leona Hakkaart‐van Roijen
PLoS ONE. 2017280 CitationsOPEN ACCESS
Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow‐up
Deniz Güngör, Michelle E. Kruijshaar, Iris Plug, Dimitris Rizopoulos, Tim A. Kanters, Stephan C.A. Wens, Arnold Reuser, Pieter A. van Doorn, Ans T. van der Ploeg
Journal of Inherited Metabolic Disease. 201570 CitationsOPEN ACCESS
Burden of illness of Pompe disease in patients only receiving supportive care
Tim A. Kanters, M.L.C. Hagemans, Nadine A. M. E. van der Beek, Frans Rutten, Ans T. van der Ploeg, Leona Hakkaart
Journal of Inherited Metabolic Disease. 201138 CitationsOPEN ACCESS
Potential cost savings owing to the route of administration of oncology drugs
M Franken, Tim A. Kanters, Jules L.L.M. Coenen, Paul de Jong, Harry R. Koene, Pieternella J. Lugtenburg, Agnes Jager, Carin A. Uyl‐de Groot
Anti-Cancer Drugs. 201836 CitationsOPEN ACCESS
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Tim A. Kanters, Iris Hoogenboom-Plug, Maureen Rutten‐van Mölken, Ken Redekop, Ans T. van der Ploeg, Leona Hakkaart
Orphanet Journal of Rare Diseases. 201434 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial